Hi Guest
X   

Real-Time Quote

Enter Company or MF 

Wockhardt Ltd.

BSE   |   NSE

532300  WOCKHARDT  Group (A) BSE data    Add to Watchlist   |  View Tips
    Zoom

How hot is this stock?  © Rediff.com

40
Price*         
Volume*         
MF holdings         
Sales         
Net profit margin         
  * Computed on last 15 days' trading figures.
Type Numbers Only
Advanced

If you had invested…

Rs ago
You would have
Rs 00,00,00,000.00

* Based on prev close (src - Rediff MoneyWiz)

Report card

AttributeValueDate
PE ratio -59.4822/05/12
EPS (Rs) -12.07Mar, 11
Sales (Rs crore) 651.72Dec, 11
Face Value (Rs)5 
Net profit margin (%) -7.45Mar, 11
Last bonus1:212/02/04
Last dividend (%)5020/02/08

Research centre

Results Statement
Balance sheet - P&L - Cash flow
More
Dividend - Bonus - Share holding
Capital structures - Ratio

MFs invested in this company 

Scheme% of asset size
Axis Midcap Fund - Growth4.17 
Axis Midcap Fund - Dividend4.17 

AnnouncementsMore

22 May   Outcome of Board Meeting   
22 May   Announces Q4 and FY12 results   
17 May   Board to consider dividend   
10 May   FY12 results on May 22, 2012   
05 May   Publish Audited Results   
24 Apr   Wockhardt launches authorized generic of Parkinson's drug Stalevo with 180-days exclusivity   
13 Feb   Announces Q3 results   
02 Feb   Q3 results on Feb 13, 2012   
10 Jan   Wockhardt launches generic version of Rhinitis drug Flonase nasal spray   
12 Nov 2011   Announces Q2 results   

Compare with

CompanyPrev close
743.25
311.95
575.80
631.90
1,870.75
110.15
214.30
924.30
1,660.60
93.65

Add Your Stock Call

    Buy        Sell      
         LTP (Rs.)   Close [x]
Time Period
Target (Rs.)
Stop Loss (Rs.)
    
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All Calls

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips